Point72 Hong Kong’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Point72 Hong Kong’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,380	Closed	-$7K	–	2525
2021 Q4	$7K	Sell	2,380 -4,347	-65%	-$14.6K	﹤0.01%	1703
2021 Q3	$24K	Buy	+6,727	New	+$25.4K	﹤0.01%	1672
2020 Q3	–	Sell	-1,054	Closed	-$5K	–	1704
2020 Q2	$5K	Buy	+1,054	New	+$4.74K	﹤0.01%	1044
2020 Q1	–	Sell	-6,747	Closed	-$43K	–	1557
2019 Q4	$43K	Buy	6,747 +6,200	+1,133%	+$36.4K	0.01%	726
2019 Q3	$2K	Buy	+547	New	+$2.34K	﹤0.01%	886

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Point72 Hong Kong's BDSI Position: Q1 2022 in Review

Point72 Hong Kong sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 2,380 shares — an estimated $7K sold.

Point72 Hong Kong first reported a position in BDSI in Q3 2019 and held it in 5 quarters. The position peaked at $43K in Q4 2019. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Point72 Hong Kong reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Point72 Hong Kong sold 2,380 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $7K.
Point72 Hong Kong first reported a position in BioDelivery Sciences International, Inc. in Q3 2019 and held it in 5 quarters.
Point72 Hong Kong's BioDelivery Sciences International, Inc. position peaked at $43K in Q4 2019.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Point72 Hong Kong's 13F filing for Q1 2022, filed 16 May 2022.